300199 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Hybio Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sales of chemically synthesized peptide drugs. Its products include atosiban, carbetocin, desmopressin, eptifibatide, ganirelix, glatiramer, terlipressin, octreotide, liraglutide, and trimetazidine tablets. The company was founded on April 2, 2003 and is headquartered in Shenzhen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
300199 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company